Role of Quality Management System (QMS) for Effective Regulatory Compliance
Ravi Chandra Vemuri.
Present day the biggest challenge faced by the pharmaceutical manufacturers is experiencing
inspectional Food and Drug administration (FDA) 483’s, warning letters, import alerts and notice
of violations from the regulatory authorities. The USFDA’s inspectional outcome has uncovered the
retesting of drug ingredients that had failed quality testing, failure to establish corrective and preventive
action following an investigation, procedural lapses etc. All these regulatory non-compliances
triggered the FDA to issue warning letters, with holding of the product approval or plant shut-down
because the US regulator has perceived violations to be of serious significance. Most experts warn that quality systems
should focus on sustainability issues and assume that quality problems and regulatory non-compliances will be reduced as
a result of the organized way of thinking, transparency, documentation and continuous evaluation of Quality Management
System (QMS). QMS is a set of coordinated activities to direct and control an organization in order to continually improve
the effectiveness and efficiency of its performance. It is designed and implemented to emphasize continuous improvement
for state of compliance. QMS starts with recognizing that customers play a significant role in defining requirements
as inputs and monitoring of customer satisfaction is necessary to evaluate and validate whether customer requirements
have been met. QMS also lives in a dynamic regulatory environment of the registration and compliance requirements
of global markets as well as inspections. As QMS is related to regulatory compliance and continuous inspection
readiness, it shall maximize benefit to the organization by improving quality, increasing the yield, cutting costs and
finally curbing FDA 483’s, warning letters and import alerts. The article details about the significance of QMS and its
modules for effective regulatory compliance.
Keywords: Inspectional FDA 483’s, Warning letters, CAPA, QMS.
Rights & PermissionsPrintExport